Table 2 Procedures and medication for clinical management of patients with ATTR-CM
Pre-cohort entry date (n = 175) | Post-cohort entry date (n = 175) | |
|---|---|---|
Procedures, n (%) | ||
Nerve conduction velocity test | 11 (6.3) | 30 (17.1) |
Pacemaker | 2 (1.1) | 7 (4.0) |
Implantable cardioverter defibrillator | - | 4 (2.3) |
Surgery for spinal stenosis | 3 (1.7) | 2 (1.1) |
Surgery for carpal tunnel syndrome | 5 (2.9) | 2 (1.1) |
Liver transplant | – | 1 (0.6) |
Heart transplant | – | 1 (0.6) |
Tissue or mechanical valve implantation | – | – |
Medication for clinical managements, n (%) | ||
Diuretic | 111 (63.4) | 149 (85.1) |
MRA | 67 (38.3) | 94 (53.7) |
ARB | 73 (41.7) | 80 (45.7) |
Statin | 57 (32.6) | 62 (35.4) |
ACE inhibitor | 29 (16.6) | 38 (21.7) |
Digitalis | 25 (14.3) | 28 (16.0) |
Isosorbide dinitrate | 12 (6.9) | 20 (11.4) |
Beta-blocker | 17 (9.7) | 12 (6.9) |
Hydralazine | – | 1 (0.6) |